Cargando…
CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response
Despite their promise, tumor-specific peptide vaccines have limited efficacy. CD27 is a costimulatory molecule expressed on CD4(+) and CD8(+) T cells that is important in immune activation. Here we determine if a novel CD27 agonist antibody (αhCD27) can enhance the antitumor T cell response and effi...
Autores principales: | Riccione, Katherine A., He, Li-Zhen, Fecci, Peter E., Norberg, Pamela K., Suryadevara, Carter M., Swartz, Adam, Healy, Patrick, Reap, Elizabeth, Keler, Tibor, Li, Qi-Jing, Congdon, Kendra L., Sanchez-Perez, Luis, Sampson, John H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279317/ https://www.ncbi.nlm.nih.gov/pubmed/30524899 http://dx.doi.org/10.1080/2162402X.2018.1502904 |
Ejemplares similares
-
A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope
por: Swartz, Adam M., et al.
Publicado: (2021) -
Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
por: He, Li-Zhen, et al.
Publicado: (2013) -
Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab
por: Ramakrishna, Venky, et al.
Publicado: (2015) -
Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity
por: Thomas, Lawrence J, et al.
Publicado: (2014) -
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity
por: Fu, Ziyi, et al.
Publicado: (2023)